Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 1998. Start Trial.
Date Value
November 19, 2026 34.76M
November 18, 2026 33.54M
November 17, 2026 33.54M
November 16, 2026 35.17M
November 13, 2026 36.63M
November 12, 2026 37.19M
November 11, 2026 35.97M
November 10, 2026 35.24M
November 09, 2026 37.19M
November 06, 2026 37.19M
November 05, 2026 35.97M
November 04, 2026 44.50M
November 03, 2026 44.50M
November 02, 2026 46.97M
October 30, 2026 51.82M
October 29, 2026 50.50M
October 28, 2026 46.45M
October 27, 2026 44.26M
October 26, 2026 45.72M
October 23, 2026 46.94M
October 22, 2026 54.50M
October 21, 2026 62.78M
October 20, 2026 66.44M
October 19, 2026 62.90M
October 16, 2026 57.35M
Date Value
October 15, 2026 57.91M
October 14, 2026 58.52M
October 13, 2026 58.30M
October 12, 2026 54.23M
October 09, 2026 52.89M
October 08, 2026 52.91M
October 07, 2026 52.30M
October 06, 2026 53.34M
October 05, 2026 49.38M
October 02, 2026 53.52M
October 01, 2026 54.25M
September 30, 2026 56.69M
September 29, 2026 57.89M
September 28, 2026 59.73M
September 25, 2026 59.02M
September 24, 2026 58.32M
September 23, 2026 65.07M
September 22, 2026 66.20M
September 21, 2026 68.04M
September 18, 2026 66.58M
September 17, 2026 69.96M
September 16, 2026 63.67M
September 15, 2026 65.12M
September 14, 2026 67.55M
September 11, 2026 66.34M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Agenus, Inc. 461.25M
Amgen, Inc. 278.17B
Anika Therapeutics, Inc. 159.06M
BioCryst Pharmaceuticals, Inc. 2.327B
Imunon, Inc. 6.407M